Skip to main content
Premium Trial:

Request an Annual Quote

Ariad Patents Technology for Regulating Gene Expression

NEW YORK, Feb 13 – Ariad Pharmaceuticals received a patent for a method to control gene expression in humans and other animals, the company said Tuesday.

The technology uses small molecules to regulate the extent of gene activation. It is part of Ariad’s Argent gene regulation system, a gene regulation technology designed for high throughput analysis of in vitro and in vivo gene function, and " dose-dependent control” of gene and cell therapy products, Ariad said.

Ariad of Cambridge, Mass., which has developed several drug candidates based on its cellular regulation technology, is making newly-patented method and accompanying technology available for license, CEO Harvey Berger said in a statement.

Ariad said it has previously licensed its other gene regulation technologies to hundreds of academic institutions.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.